![With $200M in hand, Cambridge startup EQRx sets goal: no blockbuster drugs - Boston Business Journal With $200M in hand, Cambridge startup EQRx sets goal: no blockbuster drugs - Boston Business Journal](https://media.bizj.us/view/img/11577299/melanie-nallicheri-and-alexis-borisy*1200xx8126-4577-0-0.jpg)
With $200M in hand, Cambridge startup EQRx sets goal: no blockbuster drugs - Boston Business Journal
![Blueprint's Albers hands CEO baton to deal mastermind Haviland after steering 2 cancer drug launches | Fierce Pharma Blueprint's Albers hands CEO baton to deal mastermind Haviland after steering 2 cancer drug launches | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1641397645/Jeff_Albers_and_Kate_Haviland.jpg?VersionId=Hi0P7U4jhGKw11xZE9C_7WWVQtrRAX81)
Blueprint's Albers hands CEO baton to deal mastermind Haviland after steering 2 cancer drug launches | Fierce Pharma
![With $200M in hand, Cambridge startup EQRx sets goal: no blockbuster drugs - Boston Business Journal With $200M in hand, Cambridge startup EQRx sets goal: no blockbuster drugs - Boston Business Journal](https://media.bizj.us/view/img/10152236/alexis-borisy*xx835-470-0-44.jpg)
With $200M in hand, Cambridge startup EQRx sets goal: no blockbuster drugs - Boston Business Journal
Leon 'Jun' T. on LinkedIn: Updated: EQRx acquired by Revolution Medicines, another Alexis Borisy… | 26 comments
Leon 'Jun' T. on LinkedIn: Updated: EQRx acquired by Revolution Medicines, another Alexis Borisy… | 26 comments
![Endpoints News — EQRx abandons its mission of drug price reforms; Baxter offloads biopharma biz for $4B+ Endpoints News — EQRx abandons its mission of drug price reforms; Baxter offloads biopharma biz for $4B+](https://reports.endpts.com/524130ce/46103cb0/assets/f1571f6c1bb0250c6ac1d6c64a0e153d.jpg)
Endpoints News — EQRx abandons its mission of drug price reforms; Baxter offloads biopharma biz for $4B+
![With $200M in hand, Cambridge startup EQRx sets goal: no blockbuster drugs - Boston Business Journal With $200M in hand, Cambridge startup EQRx sets goal: no blockbuster drugs - Boston Business Journal](https://media.bizj.us/view/img/11212146/12jhana-20181030genevieve-de-manio-photography*900xx3500-1969-0-184.jpg)